Harnessing machine learning and AI-driven analytics to identify novel drug targets and predict chemotherapy efficacy in NSCLC
IntroductionNon-small cell lung cancer (NSCLC) constitutes the majority of lung cancer cases and exhibits marked heterogeneity in both clinical presentation and molecular profiles, leading to variable responses to chemotherapy. Emerging evidence suggests that mitochondria-derived RNAs (mtRNAs) may s...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2025-02-01
|
| Serier: | Frontiers in Pharmacology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1555040/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
